Report Highlights
The total market for reproductive technologies and products is estimated to achieve revenues of nearly $16.1 billion in 2013. In 2018, the forecasted revenues will likely reach $19.6 billion, demonstrating a compound annual growth rate (CAGR) of 4.1%.
Report Includes
- An overview of the market for human reproductive technologies.
- Analyses of market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
- Examinations of market sizes in the categories of infertility, artificial reproductive technologies, fertility diagnostics, contraception, and sexual dysfunction, with a division of markets according to treatment type and indication.
- Evaluations of pipeline products and technologies.
- Patent analysis.
SCOPE OF STUDY
The report is designed to be a comprehensive business tool to provide an in-depth look at the markets for reproductive drugs and technologies. The geographic scope of the report is global. The report reviews male and female reproductive health, presents standard pharmaceutical treatments and devices, and reviews technologies associated with reproductive health. The report also explores market size, identifies market participants and investigates pipeline products and technologies.
The global market for reproductive technologies and products is divided into categories by treatment type and indication as follows.
- Infertility market—male and female factors, pharmaceuticals and future advancements.
- IVF.
- Assistive reproductive technologies.
- Fertility diagnostics.
- Contraception—pharmaceuticals and devices.
- Sexual dysfunction—pharmaceuticals and devices.
Each area is covered in detail, describing the disorder or treatment involved, identifying current products and treatments in the market in the base year 2013, measuring current market size and identifying current and potential market drivers, forecasting for 2018, assessing current and potential competitors and identifying current competitor market shares for the base year of 2013.
Analyst Credentials
Mary Anne Crandall is a medical research analyst and has specialized in the pharmaceuticals and medical device industry for the last 25 years. She has completed several in-depth studies on various medical topics requiring both expertise and knowledge of the industry. She is a retired nurse, has a B.S. and an M.S. in Psychology and is currently working on her Ph.D.
Related Reports
Global Markets for Catheters
The global catheter market was $17.0 billion in 2010 and $21.2 billion in 2011. This global market is projected to increase at a compound annual growth rate (CAGR) of 8.7% reaching a value of $32.1 billion by 2016.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Anesthesia and Respiratory Devices: Global Markets
The global market for anesthesia and respiratory devices is expected to grow from $51.9 billion in 2025 and is projected to reach $74.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.6% during the forecast period of 2025 to 2030.
Tissue Engineering and Regeneration: Technologies and Global Markets
The global market for tissue engineering and regeneration was valued at $4.8 billion in 2024 and is estimated to increase from $5.4 billion in 2025 to reach $9.8 billion by 2030, at a compound annual growth rate (CAGR) of 12.8% from 2025 through 2030.
6G in Healthcare: Global Market
This report provides an analysis of the global market trends for 6G in healthcare. It focuses on the significant driving trends and challenges that affect the global market. The report concludes with an analysis of the competitive landscape, which provides the ranking/share of key companies in the global market for 6G in healthcare.
Healthcare Innovation in the GCC
The report provides an analysis of the healthcare landscape in the Gulf Cooperation Council (GCC) countries. The report estimates the Total Addressable Market (TAM) for the GCC healthcare sector from 2024 to 2030, offering country-specific projections. This analysis provides critical insights into the commercial potential and investment opportunities in the region’s rapidly evolving healthcare ecosystem. The countries included in the analysis are Saudi Arabia, the United Arab Emirates (UAE), Qatar, Kuwait, Oman, and Bahrain.
Regional Analysis of the Beauty and Personal Care Market: Middle East and North Africa
This report presents an in-depth analysis of the MENA beauty and personal care market, highlighting its current and future potential. It provides a detailed examination of market drivers, restraints, challenges, opportunities, and market projections for 2030.
Report Highlights
-
The total U.S. market for reproductive technologies and products is estimated to be $6.5 billion in 2004. In 2009, revenues will likely reach $9.8 billion, rising at an average annual growth rate (AAGR) of 8.6%.
-
Contraceptive products currently account for the highest amount of revenues and are expected to grow at an AAGR of 9.1% through the period.
-
Sexual dysfunction products are expected to show the highest annual growth at an average of 12.3% through 2009.
-
Few areas in medicine have posed so many social and ethical questions and attracted so much public attention as has assisted reproductive technology (ART) to manage infertility.
Report Highlights
-
The total U.S. market for human reproductive technologies reached $6.9 billion in 2001. It is expected to rise at an AAGR (average annual growth rate) of 10.1% to $11 billion in 2006.
-
Treatments for infertility will show the most dynamic growth during the forecast period among reproductive technology products. The market for infertility treatments, both pharmaceuticals and procedures, is expected to exhibit an average annual growth rate (AAGR) of 19.7% from 2001 to 2006. Approximately 28% of the market in 2001 was generated by fertility drugs and the remainder of the market was contributed by revenues from assisted reproductive technologies (ARTs), primarily in vitro fertilization (IVF).
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More